This Article  • Full text  • PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (20)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Topic Collections  • Oncology  • Head & Neck Cancer  • Neoplasms of Head & Neck  • Radiation Therapy  • Surgical Oncology  • Alert me on articles by topic  Social Bookmarking   What's this?

K. Thomas Robbins, MD; Frank S. H. Wong, MD; Parvesh Kumar, MD; William F. Hartsell, MD; Francisco Vieira, MD; Brent Mullins, MD; H. Barry Niell, MD

Arch Otolaryngol Head Neck Surg. 1999;125:670-675.

Purpose  To determine the efficacy of targeted chemoradiation with the radiation plus platinum (RADPLAT) protocol and planned selective neck dissection in patients with N2 to N3 nodal disease associated with upper aerodigestive tract carcinoma.

Methods  Analysis of 52 patients with N2a, N2b, or N3 disease involving 60 heminecks treated with intra-arterial cisplatin, 150 mg/m², and intravenous sodium thiosulfate, 9 g/m², on days 1, 8, 15, and 22; radiation therapy, 180 to 200 cGy per fraction for 35 fractions (total dose, 68-74 Gy); and planned neck dissection (33 of 35 procedures were selective).

Results  Of the 56 evaluable heminecks, a clinical complete response was achieved in 33 (59%). Within this group, 16 neck dissections were performed, none of which yielded disease on pathological examination. A clinical partial response was obtained in 21 heminecks, of which 18 subsequently had a neck dissection, yielding disease on pathological examination in 14. In all cases, it was possible to completely excise all adenopathy with clear margins on pathological examination. The rate of regional disease control among the 56 evaluable heminecks was 91% (51/56) (median follow-up, 36 months). Four failures were associated with uncontrolled disease at other sites, and 1 was an isolated neck recurrence.

Conclusion  Selective neck dissection appears to be an effective adjunct to targeted chemoradiation in controlling N2 to N3 neck disease.

From the Departments of Otolaryngology–Head and Neck Surgery (Drs Robbins, Wong, and Vieira), Radiation Oncology (Drs Kumar and Hartsell), and Hematology-Oncology (Drs Mullins and Niell), University of Tennessee, Memphis, College of Medicine.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Prospective Study on Neck Dissection after Primary Chemoradiation Therapy in Stage IV Pharyngeal Cancer
BREMKE et al.
Anticancer Res 2009;29:2645-2653.
ABSTRACT | FULL TEXT  

Interventional Neuroradiology of the Head and Neck
Gandhi et al.
Am. J. Neuroradiol. 2008;29:1806-1815.
ABSTRACT | FULL TEXT  

Superselective Neck Dissection After Chemoradiation: Feasibility Based on Clinical and Pathologic Comparisons
Robbins et al.
Arch Otolaryngol Head Neck Surg 2007;133:486-489.
ABSTRACT | FULL TEXT  

RADPLAT: An Alternative to Surgery?
Alkureishi et al.
The Oncologist 2006;11:469-480.
ABSTRACT | FULL TEXT  

Effectiveness of Superselective and Selective Neck Dissection for Advanced Nodal Metastases After Chemoradiation
Robbins et al.
Arch Otolaryngol Head Neck Surg 2005;131:965-969.
ABSTRACT | FULL TEXT  

Recurrence Rates After Selective Neck Dissection in the N0 Irradiated Neck
Fritz et al.
Arch Otolaryngol Head Neck Surg 2002;128:292-295.
ABSTRACT | FULL TEXT  

Analysis of Risk Factors Predictive of Distant Failure After Targeted Chemoradiation for Advanced Head and Neck Cancer
Doweck et al.
Arch Otolaryngol Head Neck Surg 2001;127:1315-1318.
ABSTRACT | FULL TEXT